amalga-close-upMicrosoft now prepares to explore new avenues in health care industry with its announcement to acquire Rosetta Biosoftware, a unit of Merck & Co. The company develops software for analyzing genomes and conducting clinical studies. Microsoft plans to administer Rosetta's assets into its health industry research management software platform - Amalga Life Sciences. Amalga was established in April, 2009 with the intentions of a new software system designed to transform healthcare and life science research data into the critical knowledge needed for the discovery of new personalized treatments. With the acquisition Microsoft will be able to incorporate genetic, genomic, metabolomic and proteomics data sets into the Amalga software.
Full article (238 words) »